Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I voted NO on the increase of A/S for the reasons I have previously written about.
Its absolutely not the end of the world if they dont get that vote. In that case, they can reschedule a new Stockholders Meeting after they are able to communicate to shareholders what the reason is for the increase of A/S or after they have provided a simple explanation of how they plan to move forward. In other words, I hope they have learned their lesson from a no-vote.
I also voted NO on the question if I want to reaffirm the stock option awards to the Company’s executive officers and to the independent directors on the Company’s Board of Directors for the simple reason that I find the stocks, options, and warrant awarded to them (approx 250 million in common shares after converted) insane for work delivered (EX Bosch). But I could not vote separately per person.
Its interesting they did not ask for a reconfirmation of the warrants awarded to them which make up for the bulk. In my view, they have put themselves in a vulnerable legal spot by asking shareholders to reaffirm the awarded options, and with yesterday's proxy stating they will ask the court to dismiss the lawsuit if the quorum vote turns out YES. What if it turns out shareholders will vote NO? Will they then THUS return a large part of the bulk of the awarded warrants and options to NWBO?
For the rest, I voted yes.
euh duh now I get with what you are saying, hahahah yes agreed
Agreed. That is my guess as well.
hahahahahahah lol hahahah thats very funny Flipper
The news is not so much that she left the news is that they have not replaced her position..
exactly. Especially when the self-appointed spokesperson is crazy as a bat.
I voted no on my 550k shares
question for you
There are millions of people that love soccer in the US they can tell their friends how great the game is so that would spread it into the tens and tens of millions of soccer fans in the US. Yet baseball, Football, and Basketball are more popular, why is that?
So that simulates the logic you are trying to convey here lol
Only thing they need todo is to explain what their intentions are with the 500 million increase of A/S, so shareholders know what they are voting for that's all.
Im voting NO on all accounts as long the explanation remains absent of what their intentions are with the 500 million increase of A/S. I advise everyone to do the same.
There is a complete lack of explanation communication by NWBO management on what the increase in A/S is for so shareholders voting no or not voting is the best way of communicating back. You cant vote on something you dont know what the vote is for, what the dilution is for, what the game plan for 2023 is.
As I have said a few large shareholders I know will abstain from their vote which in essence is a no vote.
Im predicting they will NOT get the increase of A/S under the present circumstances.
thanks
So where do you stand now?
Do you expect Anavex having to initiate a Phase 3 trial with the correct dose info from this trial?
Im now at 50/50 change they will have to initiate a new trial. I also believe the market will not appreciate Anavex until there is more confirmation approval is HIGHLY likely based on present data.
Jeez ex get over yourself in 2007 in 2015.
The First Crusade (1096–1099) was the first of a series of religious wars,
Do you agree with this?
Ooh sorry I thought you liked history
pffff Im at 90% sure now we will see a Phase 3 trial
Ok AD is an orphan non the less TGA will not approve if not approved by EMA:
https://www.ema.europa.eu/en/partners-networks/international-activities/bilateral-interactions-non-eu-regulators/australia
Australia
The European Medicines Agency and the European Commission have had confidentiality arrangements with the Therapeutic Goods Administration (TGA) of the Australian Government Department of Health and Ageing since 2012, to allow the exchange of information between the parties as part of their regulatory and scientific processes. The European Union (EU) and Australia also have a mutual recognition agreement (MRA) in place on good manufacturing practice (GMP) compliance.
Confidentiality arrangement
EMA, the European Commission and TGA signed a confidentiality arrangement in 2012.
The confidential information that EMA and TGA can share includes:
guidance documents, policies, procedure and other technical documents;
post-authorisation pharmacovigilance data, particularly in relation to adverse drug reactions, as well as safety concerns arising from periodic safety update reports and post-authorisation obligations and commitments;
applications for scientific advice, orphan designation, marketing authorisation or post-authorisation activities of significant public health interest and complementary medicine listings;
cases, or possible cases, of counterfeit therapeutic goods and medicines;
risk management plans;
administrative arrangements including fees and charges;
information technology systems supporting regulatory processes
It will be very difficult to get approval in Australia if the EMA is not on board.
https://www.ema.europa.eu/en/news/ema-australian-regulator-strengthen-collaboration-area-orphan-medicines
Missling promised a peer-reviewed article in a top-tier Medical journal.
Its either the questions asked from posters like Doc328 or its peer reviewers who will be asking the same questions raised here. I bet the reviewers and journal editorial will not let Anavex get away with how the data is presented now. At least a JA will not come from it.
100% agree
have you noticed? Not one of the defendants has come out to dispute any wrongdoing spoofing or otherwise. That is saying a lot.
Instead, Citadel chooses to start throwing mud:
they are claiming damages in excess of 49 million shares sold at depressed prices, lets say 50 cents, which should have been lets say $5? The difference is then $220 million. So how would they be able to claim $ 500 million in damages suffered?
welcome,
I do believe the lawsuit has a good chance for NWBO to win this. Also, I believe it will be settled before that.
If this is Citadels main defense then then they are in deep trouble
interesting
Im 75% certain Anavex will need an additional trial to iron out the already mentioned insurmountable. Not for nothing, Anavex mentions counseling the FDA for follow-up advice.
I do expect a run in the SP but then after reality sets in probably to walk back again. JMHO
Btw I think its outrageous Anavex has called it met endpoints when at the same time they have made these incredibly stupid mathematic errors